Navigation Links
GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding
Date:3/6/2008

(Local Nonprofits Receive the GlaxoSmithKline 11th Annual IMPACT Awards)

PHILADELPHIA, March 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK), one of the world's leading research-based pharmaceutical and healthcare companies, has announced the recipients of the GlaxoSmithKline 11th Annual IMPACT Awards. Nonprofits from five area counties will each receive $40,000 in unrestricted funding. They include the Center for Families and Relationships of Philadelphia, the Clinic for Special Children, Inc., of Lancaster County, Community Medical and Dental Center of Montgomery County, Health Quality Partners of Bucks County, the Hepatitis B Foundation of Bucks County, the Linda Creed Breast Cancer Foundation of Philadelphia, the Supportive Older Women's Network of Philadelphia and the Western Berks Free Medical Clinic, Inc., of Berks County. An award ceremony will be held on Thursday, March 20 at the GlaxoSmithKline headquarters in Philadelphia.

"These organizations have committed themselves to promoting health and well-being. Their missions focus on outcomes that improve the quality of human life despite the numerous challenges they face as they help those who are less fortunate. All of the winners are committed to the idea that everyone should have better access to healthcare -- that no one should be left behind," said MaryLinda Andrews, GlaxoSmithKline Director, Community Partnerships.

The Center for Families and Relationships serves the needs of single parents, children at risk, couples, families and individuals through comprehensive family and art therapy services. The organization's warm and welcoming setting in Northeast Philadelphia provides a safe place where troubled families can feel at home.

The Clinic for Special Children, located in Strasburg, Pennsylvania, provides the Amish and Mennonite communities with medical services for children with genetic disorders including diagnoses, comprehensive medical care and education abou
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
2. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
3. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
4. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
5. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
6. AUDIO from Medialink and GlaxoSmithKline: Setting Realistic Goals for a New You in the New Year
7. AUDIO from Medialink and GlaxoSmithKline: Shifting Your Focus for a Lighter, Healthier New Year
8. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
9. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...pellents suspected in birth defect that affects ma...Y, Dec. 2 (HealthDay News) -- Male babies of women...months of pregnancy appear to be at increased risk...s report. , This birth defect, which affects ab...ure shortening of the urethra, the tube that carri...
(Date:12/2/2009)...OR, Mich. Even when women at high-risk of breast ...its of using the drug tamoxifen for prevention, on... Researchers at the University of Michigan Compreh...ed to inform women about the risks and benefits as...d to stop breast cancer from returning and has rec...
(Date:12/2/2009)... NCDecember 2, 2009Ninety-six percent of low-incom...nder-based distrust indicated a strong general fee...s general distrust towards men did not prevent the...tic relationship. Furthermore, the union was often...," despite their prior assertions of distrust and ...
(Date:12/2/2009)...tists may not be able to tell a good book by its c...d book by its smell. In a report in ACS, Analytic...be development of a new test that can measure the ...ocuments based on their smell. The nondestructive ...erve a range of prized paper-based objects, some o...
(Date:12/2/2009)...mpions Biotechnology, Inc. (OTC Bulletin Board: CS... a predictive preclinical platform aimed at accele...oncology drugs, has established an exclusive licen...td., Tel Aviv University,s wholly owned technology...compasses the development and commercialization of...
Breaking Medicine News(10 mins):Health News:High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds 2Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2
...ll gain access to innovative medical, education an...st satellite, radio channel created for medical pr...ug. 27 ReachMD XM 157 announced today a new,strat...ians-in-training., Gary Epstein, CEO of ReachMD, ...
...apeutic Radiology and Oncology has selected renown... 2008 honorary member. Dr. Evans will be recognize...er 23, at 10:00 a.m. during ASTRO,s 50th Annual Me...e original Ronald McDonald House, which opened in ...
...of preterm birth cuts risk in half, study finds , ...agnesium sulfate, given to mothers at risk of pret...eir babies by nearly half, a new study found. , "I...ir child from having cerebral palsy," said study l...
...ated with treating ,wet, form of the eye disease ,...Scientists from the United States and China have i...the onset of severe "dry" macular degeneration, on...n work with both human and mice cells, centers on ...
...CT Corporation,(Nasdaq: DRRX ) today reported tha..., has submitted an Investigational New Drug (IND) ...on (FDA) for an abuse-resistant opioid,pain drug c... Pain Therapeutics, for which King Pharmaceuticals...
...e it or not,women and men have different oral heal...e at different stages throughout their life, inclu...ylvania Dental Association (PDA) offers a reminder...they,need to maintain healthy teeth and gums., Ch...
Other Medicine News:Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Magnesium Sulfate Reduces Threat of Cerebral Palsy 2Health News:Magnesium Sulfate Reduces Threat of Cerebral Palsy 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3Health News:DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology 2Health News:DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology 3Health News:What You Need to Know About Women's Oral Health 2
(Date:12/2/2009)... , ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCal...d favorable initial results from the first stage o...e safety and immunogenicity of the company,s 2009 ...vaccine. Novavax is conducting this study in coll...pport registration of the vaccine in Mexico and po...
(Date:12/2/2009)... , PLEASANTON, Calif., Dec. 2 /PRNewswire-Firs...nced today that the United States Food & Drug ...ed use for its licensed nucleic acid test, to scre...dividual donations. The test, called the cobas... system, is a qualitative, in-vitro test for the s...
(Date:12/1/2009)... , MONTREAL and DUSSELDORF, Germany, ...eading manufacturer of specialized graphics soluti...mbH is now shipping the Matrox Xenia(TM) Series d...S and Mammography solutions using Fujifilm Synaps... in computer based radiography, offering the world...
Breaking Medicine Technology:NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Wistar Institute team finds key target of aging regulator 48508 1Wistar Institute team finds key target of aging regulator 48508 2CAP Announces Health Care Reform Agenda 48504 1CAP Announces Health Care Reform Agenda 48504 2CAP Announces Health Care Reform Agenda 48504 3FDA Panel Mulls Newer Antipsychotics for Kids 48499 1FDA Panel Mulls Newer Antipsychotics for Kids 48499 2FDA Panel Mulls Newer Antipsychotics for Kids 48499 3FDA Panel Mulls Newer Antipsychotics for Kids 48499 4
...nd Associated Microbial Genomes to Understand and ...e Fuels, Biofertlizers, and Disease Control Soluti...ne Accomplishment for Partners who Announced Compl..., Calif. and KUALA LUMPUR, Malaysia, May 20 Synth... applying genomic-driven commercial solutions to a...
...monstrate that maintenance therapy with RISPERDAL(...RLAT) significantly delayed the time to relapse co...der. Results of the study were presented this week...er is a brain disorder that causes unusual shifts .... It is often characterized by debilitating mood s...
Other Medicine Technology:First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology 2First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology 3RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 2RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 3RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 4RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 5RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 6RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 7RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 8RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 9RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 10
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: